14:54 11/09 UTC — Bullish
US equity indices are bouncing sharply in intraday trading, led by SPY and QQQ pushing through key resistance zones ahead of upcoming CPI data. Semiconductor activity is intense, as NVDA faces high volume and mixed sentiment over executive headlines while AMD rallies strongly. Speculative biotech names like IBRX face steep declines following quarterly earnings miss.
Major equity indices are staging a strong intraday rebound following recent selloffs, with SPY and QQQ testing key upside pivot zones ahead of upcoming CPI data. The semiconductor space is showing significant intraday momentum led by AMD, while NVDA navigates heavy headline volatility surrounding its CEO alongside active dip-buying. Smaller-cap biotechs face earnings-related pressure, but broader market sentiment remains risk-on for the immediate term.
Outlook
Bullish · Intraday (Medium)
Base — Likely
SPY holds the 747-748 pivot zone and pushes toward 750 as tech buying continues.
Bull — Possible
Broad short squeeze drives QQQ toward the 685-700 range on cooler inflation expectations.
Bear — Unlikely
Intraday rally fades if NVDA headlines roll tech over and push SPY back to test lower bounds around 742.
Hot tickers
- NVDA Mixed — High intraday volatility following security/affair headlines involving CEO Jensen Huang, met with aggressive retail dip-buying after hitting early lows.
- SPY Bullish — Rebounding strongly off recent lows, breaking into the 747-748 decision zone with calls in high demand.
- AMD Bullish — Continuing a sharp multi-day post-earnings rally, with traders eyeing further upside momentum.
- IBRX Bearish — Stock under heavy selling pressure after reporting its first sequential quarterly revenue decline and wider net loss.
- QQQ Bullish — Surging tech-heavy ETF tracking broad market rebound alongside falling crude oil prices.
Themes
- Tech & AI Volatility Driven by NVDA Headlines
- Intraday Market Rebound Ahead of CPI Print
- Biotech Q3 Earnings Disappointments
Risks
- Spillover effects from NVDA executive narrative and security leaks
- Volatile positioning ahead of the upcoming CPI report
- Sequential revenue declines triggering sharp drawdowns in mid-cap biotech
Get digest by email Open live dashboard All digests About FC Global